Therapeutic Effects of Music on Procedural Outcomes
TEMPO
Effect of Intra-Procedural Low-Tempo Instrumental Music Plus Standard Sedation Versus Standard Sedation Alone on Sedative Requirements in Adults Undergoing Gastroscopy and/or Colonoscopy: a Single-Center, Parallel-Group, Randomized Superiority Trial With Blinded Outcome Assessors and Statisticians
1 other identifier
interventional
180
1 country
1
Brief Summary
This study will evaluate whether listening to low-tempo instrumental music during gastroscopy and/or colonoscopy can reduce the amount of sedative medication needed during the procedure. Adults undergoing elective gastroscopy and/or colonoscopy with sedation will be randomly assigned to one of two groups. One group will listen to low-tempo instrumental music (60-80 beats per minute) through headphones during the procedure in addition to receiving standard sedation. The other group will receive standard sedation without music. The main outcome of the study is the amount of sedative medication required during the procedure. The study will also compare pain after the procedure, time until discharge, patient satisfaction, and changes in heart rate and blood pressure between the two groups. The researchers hypothesize that patients who listen to low-tempo music will require less sedative medication and may have improved recovery and patient-reported outcomes compared with patients receiving standard sedation alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 9, 2026
CompletedFirst Posted
Study publicly available on registry
August 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
CompletedAugust 13, 2026
August 1, 2026
2 months
August 9, 2026
August 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Total Propofol Dose Requirement During the Endoscopic Procedure
Total propofol dose administered to each participant during procedural sedation will be calculated as the cumulative dose administered from the start of sedation until the end of the gastroscopy and/or colonoscopy and normalized to body weight (mg/kg). The mean total propofol dose in mg/kg will be compared between the randomized groups.
From first administration of procedural sedation until the end of the endoscopic procedure on the day of enrollment
Secondary Outcomes (4)
Mean Post-Procedural Pain Intensity on the 0-10 Numeric Rating Scale
10 minutes after entry to the recovery room and immediately before discharge from the recovery room
Mean Time From End of Procedure to Recovery Room Discharge
From end of the endoscopic procedure until exit from the recovery room
Overall Patient Satisfaction With the Endoscopic Procedure
Before discharge from the recovery room on the day of the procedure
Requirement for Rescue Analgesia in the Recovery Room
From entry into the recovery room until recovery room discharge on the day of the procedure
Other Outcomes (5)
Mean Intra-Procedural Mean Arterial Pressure
From initiation of procedural sedation until the end of the endoscopic procedure, assessed at 10-minute intervals
Mean Intra-Procedural Heart Rate
From initiation of procedural sedation until the end of the endoscopic procedure, assessed at 10-minute intervals
Mean Intra-Procedural Peripheral Oxygen Saturation
From initiation of procedural sedation until the end of the endoscopic procedure, assessed at 10-minute intervals
- +2 more other outcomes
Study Arms (2)
Low-Tempo Music Intervention
EXPERIMENTALParticipants will receive standard procedural sedation and will listen to low-tempo instrumental music (60-80 beats per minute) through headphones throughout the gastroscopy and/or colonoscopy. Before randomization, headphones will be tested using a standardized test audio and the volume will be adjusted to a comfortable level. During the procedure, a uniquely identified audio file containing the study music will be played by masked research personnel.
Silent Audio Control
SHAM COMPARATORParticipants will receive standard procedural sedation and will wear identical headphones throughout the gastroscopy and/or colonoscopy. Before randomization, headphones will be tested using the same standardized test audio and the volume will be adjusted to a comfortable level. During the procedure, a uniquely identified silent audio file will be played by masked research personnel. The audio player will progress in the same manner as in the intervention group.
Interventions
Standardized instrumental music with a tempo of 60-80 beats per minute will be delivered through headphones during the endoscopic procedure. Playback will begin after application of the headphones and continue throughout the procedure. The intervention is provided in addition to standard procedural sedation.
A silent audio file will be delivered through identical headphones during the endoscopic procedure. The file will play and progress in the same manner as the active music file but will contain no audible music. The control procedure is provided in addition to standard procedural sedation.
Eligibility Criteria
You may qualify if:
- Age ≥18 years.
- Scheduled for elective gastroscopy (upper gastrointestinal endoscopy), colonoscopy, or both under procedural sedation.
- Able to provide written informed consent.
You may not qualify if:
- Emergency or urgent endoscopic procedure.
- Hearing impairment that prevents adequate perception of the standardized test audio through the study headphones.
- American Society of Anesthesiologists (ASA) Physical Status IV or higher.
- Cognitive impairment, altered mental status, or another condition that prevents provision of informed consent or reliable completion of study assessments.
- Any condition that prevents safe or appropriate use of the study headphones.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bahaa Bou Darghamlead
- Beirut Arab Universitycollaborator
- Hammoud Hospital University Medical Centercollaborator
Study Sites (1)
Hammoud Hospital University Medical Center (HHUMC)
Sidon, Lebanon
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bahaa W Bou Dargham, MD
Beirut Arab University / Hammoud Hospital University Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants in both groups will undergo an identical headphone setup and pre-procedure test audio. After enrollment, a dedicated study platform will provide the investigator with a uniquely identified audio file corresponding to the randomized allocation. Investigators and care providers will not have access to the allocation sequence or know whether the assigned file contains low-tempo music or silence. The allocation sequence and audio-file mapping will be maintained by an independent individual not involved in enrollment, intervention delivery, outcome assessment, or analysis. Post-procedure outcome assessors will remain masked, and participants will be instructed not to disclose whether they heard music until all masked assessments are completed. Statistical analysis will be performed using coded groups, with the statistician masked to allocation until the prespecified analysis is completed.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Anesthesia & Reanimation Consultant and Lecturer of Anesthesia
Study Record Dates
First Submitted
August 9, 2026
First Posted
August 13, 2026
Study Start
August 1, 2026
Primary Completion
October 1, 2026
Study Completion
October 1, 2026
Last Updated
August 13, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data are not currently planned to be shared with external researchers because the approved study protocol limits access to study data to investigators directly involved in the study. De-identified aggregate study results will be disseminated through the trial registry, scientific presentations, and peer-reviewed publication.